MedTrace Logo

Investigation on the Effect of Carnitine Supplement on Gut Microbiota and TMAO Production Capacity

NCT02838732 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2023-12-18

No results posted yet for this study

Summary

In this project, the investigators aim to explore the impact of dietary L-carnitine supplementation on the TMAO production capacity of gut microbiota.

Conditions

  • Dietary Exposure

Interventions

DIETARY_SUPPLEMENT

L-carnitine supplementation (500 mg per tablet per day, purchased from GNC company)

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Ming-Shiang Wu, MD, PhD · National Taiwan University Hospital

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-18
Primary Completion
2017-11-20
Completion
2019-10-07

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02838732 on ClinicalTrials.gov